Short stature and delayed skeletal maturation in children with allergic disease

Ferguson, Alexander C.; Murray, Andrew B.; Tze, Wah Jun

doi:10.1016/0091-6749(82)90122-1

Cited by 83 publications

(42 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Those men (n = 4,927) who were classified as having diseases known to influence growth and final height [19, 20, 21, 22, 23]were excluded (table 1). In addition, height data were missing for 1,086 individuals.…”

Section: Methodsmentioning

confidence: 99%

Intellectual and Physical Performance and Morbidity in Relation to Height in a Cohort of 18-Year-Old Swedish Conscripts

Tuvemo

Jonsson²,

Persson

1999

Horm Res Paediatr

View full text Add to dashboard Cite

To test whether short stature in young men without malformations or chronic childhood diseases is associated with intellectual and physical performance and morbidity, a large cohort of apparently healthy 18-year-old Swedish men was analysed. The original cohort consisted of all men born in 1976 and conscripted in 1994 (n = 38,900). After exclusion due to growth-affecting disorders or missing data, 32,887 subjects were available for analysis. Short conscripts (height below or equal to –2 SD scores) demonstrated increased overall morbidity compared with taller conscripts (above –2 SD scores). Specifically, short conscripts had more psychiatric and musculoskeletal diagnoses and were more often considered psychologically unsuitable for military service. Mean intellectual performance increased continuously with height; the mean ‘standard nine’ score was 4.22 for the short men and 5.17 for the rest (p < 0.001). Short conscripts scored less well than taller conscripts in assessment of psychological functioning during mental stress, and were evaluated as less suitable for leadership positions. Maximal working capacity per kilogramme body weight correlated negatively with height (p < 0.001). In conclusion, short stature was associated with increased morbidity and psychological problems and with lower mean intellectual performance. To what extent this association is direct or indirect needs further evaluation.

show abstract

Section: Methodsmentioning

confidence: 99%

Intellectual and Physical Performance and Morbidity in Relation to Height in a Cohort of 18-Year-Old Swedish Conscripts

Tuvemo

Jonsson²,

Persson

1999

Horm Res Paediatr

View full text Add to dashboard Cite

show abstract

“…On the contrary, growth impairment has been observed in asthmatic children not on glucocorticosteroids regardless of the severity of their disease [40][41][42]. Since similar observations have been made in children with allergic rhinitis [41] and atopic dermatitis [45,46] it has been suggested that the retardation of growth may represent a physiological pattern associated with the atopic condition per se [41,45].…”

Section: Asthma and Growthmentioning

confidence: 66%

Long-, intermediate- and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids

Wolthers¹

1996

Eur Respir J

View full text Add to dashboard Cite

During recent years, new auxological techniques have been introduced for assessment of the risk of growth suppression in asthmatic children treated with exogeneous glucocorticosteroids. Assessment of lower leg growth rates with the knemometer has made short-term studies of growth processes under strictly controlled conditions possible. However, short-term lower leg growth rates cannot be used for estimations of intermediate-term height growth rates or long-term evaluations of final height. Consequently, the distinctions between the various types of growth studies in asthmatic children treated with inhaled glucocorticosteroids have become important and need to be discussed.The present paper presents a review of the long-, intermediate-and short-term growth studies available. The bulk of evidence from intermediate-and short-term evaluations indicates that growth rate is not affected when standard paediatric doses of inhaled glucocorticosteroids are used. However, further focus needs to be placed on differences between specific glucocorticosteroids, doses and delivery systems. Intermediate-and short-term growth data should be evaluated in the long-term perspective.

show abstract

“…27 A slow tempo of growth, often associated with late onset of puberty, is a characteristic of asthma and is independent of disease severity or treatment. 28,29 Despite this retardation in growth rate, most children with asthma, with the possible exception of those with very severe disease, attain a normal final height. 30,31 The frequency of symptoms and the degree of asthma control has important effects on the growth rate.…”

Section: Long-term Growth Growth In Asthmamentioning

confidence: 97%

Inhaled corticosteroids: Clinical relevance of safety measures

Price¹

1997

Pediatr. Pulmonol.

View full text Add to dashboard Cite

Short stature and delayed skeletal maturation in children with allergic disease

Cited by 83 publications

References 24 publications

Intellectual and Physical Performance and Morbidity in Relation to Height in a Cohort of 18-Year-Old Swedish Conscripts

Intellectual and Physical Performance and Morbidity in Relation to Height in a Cohort of 18-Year-Old Swedish Conscripts

Long-, intermediate- and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids

Inhaled corticosteroids: Clinical relevance of safety measures

Contact Info

Product

Resources

About